ADGRG6 and chronic obstructive pulmonary disease: A separate analysis of this variant found that expression of ADGRG6 in human lung tissue was decreased in COPD patients and in individuals with decreased pulmonary ventilatory function, suggesting this variant may also be functional (Terzikhan et al., 2018).